Alembic Pharmaceuticals consolidated net profit rises 20.40% in the September 2025 quarter

Sales rise 15.91% to Rs 1910.15 crore

Net profit of Alembic Pharmaceuticals rose 20.40% to Rs 184.71 crore in the quarter ended September 2025 as against Rs 153.41 crore during the previous quarter ended September 2024. Sales rose 15.91% to Rs 1910.15 crore in the quarter ended September 2025 as against Rs 1647.98 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1910.15	1647.98	16
OPM %	16.53	14.52	-
PBDT	299.79	238.06	26
PBT	223.72	167.55	34
NP	184.71	153.41	20

Powered by Capital Market - Live News